Stromal Mystery with Cellular Secrets - Navigating Tumor Terrain: Insights Into Endometrial Tumors
DOI:
https://doi.org/10.52783/jns.v14.2030Keywords:
Cellular leiomyoma, endometrial stromal sarcoma, endometrial stromal tumorAbstract
Uterine smooth muscle tumors and endometrial stromal tumors (ESTs) are the two major types of mesenchymal tumors of the uterus, the latter being fairly uncommon. Among these, endometrial stromal sarcoma (ESS) accounts for less than 1% of all uterine tumours. Endometrial stromal tumors (ESTs) are rare uterine mesenchymal neoplasms and on occasion pose a diagnostic dilemma for pathologists if it coexists with leiomyomata.[1] According to the current WHO classification, they have been categorized into endometrial stromal nodule, low-grade endometrial stromal sarcoma (LG‑ESS), high‑grade ESS, and undifferentiated uterine sarcoma. Cellular leiomyoma (CL) often simulates EST due to increased cellularity. We hereby report a series of 4 cases which posed a diagnostic challenge to us as all the cases had concurrent leiomyoma along with ESTs. We therefore discuss the histological features of ESTs which helped us resolve this dilemma as well as the utility of immunohistochemistry (IHC) as a diagnostic aid in arriving at a final diagnosis in such problematic cases.
Downloads
Metrics
References
Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO Classification of Tumors of Female Reproductive Organs. 4th ed. Lyon, France: IARC Press; 2014. p. 307.
Toki T, Shimizu M, Takagi Y, Ashida T, Konishi I. CD10 is a marker for normal and neoplastic endometrial stromal cells. Int J Gynecol Pathol. 2002;21(1):41–7. https://doi.org/10.1097/00004347-200201000-00008.
Chu PG, Arber DA, Weiss LM, Chang KL. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: An immunohistochemical comparison of 34 cases. Mod Pathol. 2001;14(5):465–71. https://doi.org/10.1038/modpathol.3880335.
McCluggage WG, Sumathi VP, Maxwell P. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology. 2001;39(3):273–8. https://doi.org/10.1046/j.1365-2559.2001.01215.x.
Vera AA, Guadarrama MB. Endometrial stromal sarcoma: Clinicopathological and immunophenotype study of 18 cases. Ann Diagn Pathol. 2011;15(5):312–7. https://doi.org/10.1016/j.anndiagpath.2011.01.008.
Oliva E. CD10 expression in the female genital tract: Does it have useful diagnostic applications? Adv Anat Pathol. 2004;11(6):310–5. https://doi.org/10.1097/01.pap.0000138140.81139.46.
Oliva E, Young RH, Amin MB, Clement PB. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: A study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies. Am J Surg Pathol. 2002;26(4):403–12.
Zhu XQ, Shi YF, Chang XD, Zhao CL, Wu YZ. Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma. Gynecol Oncol. 2004;92:71–9.
Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO Classification of Tumors of Female Reproductive Organs. 4th ed. Lyon, France: IARC Press; 2014. p. 307.
Puliyath G, Nair MK. Endometrial stromal sarcoma: A review of the literature. Indian J Med Paediatr Oncol. 2012;33(1):1–6.
Mutter GL. Endometrial tumors. In: Fletcher CD, editor. Diagnostic Histopathology of Tumors. 4th ed. Elsevier; 2013. p. 762–83.
Conklin CM, Longacre TA. Endometrial stromal tumors: The new WHO classification. Adv Anat Pathol. 2014;21(6):383–93.
Elagoz S, Kıvanc F, Aker H, Arici S, Ozer H, Güvenal T, et al. Endometrial stromal tumors: A report of 5 cases. Aegean Pathol J. 2005;2:140–5.
Pujani M, Jairajpuri ZS, Rana S, Jetley S, Hassan MJ, Jain R. Cellular leiomyoma versus endometrial stromal tumor: A pathologist’s dilemma. J Midlife Health. 2015;6(1):31–4.
Liao X, Wang Y, Yue C, Liu Y, Wang H, Dai L, et al. Highly cellular leiomyoma of uterus: A comparative morphologic and immunohistochemical study of endometrial stromal tumors. Zhonghua Bing Li Xue Za Zhi. 2002;31(5):396–400.
Oliva E, Clement PB, Young RH. Endometrial stromal tumors: An update on a group of tumors with a protean phenotype. Adv Anat Pathol. 2000;7(5):257–81.
Rajendran AB. ER, PR status in leiomyomas - A study of 102 cases in rural Tamil Nadu. IP Arch Cytol Histopathol Res. 2020;5(1):3–8.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
